ChemBriefLanxess maintains full-year outlook despite challenging environment
Lanxess AG confirmed its full-year 2026 EBITDA guidance of €450-550 million after Q2 sales rose 6.5% year over year. While market conditions remain challenging, the specialty chemicals firm expects co
chemweek · 2026-08-07 17:32 UTC